Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, adenocarcinoma, biliary tract cancer, biliary tract disorder, breast disorder, breast neoplasm, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, liver disorder, neoplasm, pancreatic ductal adenocarcinoma, skin disorder, squamous cell carcinoma, squamous cell neoplasm, triple-negative breast carcinoma	Recruiting	Phase 1	2026-08-24		NCT06084481

Clinical trials